In
Institut Curie
NPParis FRFounded 19093,500 employees
Private CapacadPrivateOncology
Platform: Cancer Research
Market Cap
N/A
All Drugs
4
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| INS-IIT-597 | INS-IIT-597 | Phase 2/3 | 1 | VEGF | LGS | ||
| INS-IIT-594 | INS-IIT-594 | Approved | 1 | GPRC5D | Celiac | ||
| INS-IIT-499 | INS-IIT-499 | Preclinical | 1 | TROP-2 | Wet AMD | ||
| INS-IIT-513 | INS-IIT-513 | Phase 3 | 1 | CD47 | FSGS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)